Mitochondrial disease treatments: Is a breakthrough coming?

Swiss biopharma Vandria is working on treatments to restore mitochondrial function to treat age-related diseases such as neurodegeneration. Rather than focusing on the DNA inside the mitochondria, which when disturbed leads to illness, Vandria’s drugs induce a process known as mitophagy, a safer approach to maintain cellular health. British biotech NRG Therapeutics is also developing small molecule drugs for conditions such as Parkinson’s disease and ALS.